Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company provides branded specialty medicines in various therapeutic areas, such as cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, veterinary, and anti-diabetic; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products. The company was founded in 1907 and is headquartered in Vadodara, India.
Metrics to compare | ALEM | Peers Peers - average of corresponding metrics from companies closely matching ALEM: GLAXO, MOREPENLAB, MANKIND, GLENMARK, PFIZER | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALEMPeersSector |
---|---|---|---|---|
P/E Ratio | 36.6x | 36.0x | −0.6x | |
PEG Ratio | 1.92 | 0.39 | 0.00 | |
Price/Book | 4.8x | 6.4x | 2.6x | |
Price / LTM Sales | 3.7x | 5.1x | 3.2x | |
Upside (Analyst Target) | −3.6% | −3.5% | 46.9% | |
Fair Value Upside | Unlock | −16.5% | 7.9% | Unlock |